Nuritas Raises $45 Million in Series B  

by Kay Aloha Villamor in November 12th, 2021

Nuritas, a Dublin, Ireland-based biotechnology company revolutionizing the discovery and development of plant-based bioactive peptides, has closed a $45 million Series B funding round. 

The investment, led by Chicago-based Cleveland Avenue, LLC, includes Grosvenor’s Wheatsheaf Group, the European Circular Bioeconomy Fund (ECBF), Singapore-based Vertex Holdings, Nutres Ventures/ Veronorte, and CJ.

Cultivian Sandbox Ventures and VisVires New Protein, who led previous rounds, also participated. Other early investors include U2’s Bono and The Edge, Salesforce CEO Marc Benioff, and Ali Partovi. Total funding to date is $75 million.

The new funding will accelerate Nuritas’ global expansion and support its mission to unlock the power of nature to make many of the products we consume daily healthier, safer, and more sustainable. 

Company: Nuritas Limited

Raised: $45.0M

Round: Series B

Funding Month: November 2021

Lead Investors: Cleveland Avenue

Additional Investors: Grosvenor’s Wheatsheaf Group, European Circular Bioeconomy Fund (ECBF), Vertex Holdings, Nutres Ventures/ Veronorte, CJ, Cultivian Sandbox Ventures, VisVires New Protein, Marc Benioff, and Ali Partovi

Company Website:

Software Category: Peptide Discovery Platform

About the Company: Nuritas is revolutionizing the discovery of novel, natural, and scientifically proven bioactive ingredients that enable their partners to create better or new product solutions for their customers. The company’s disruptive computational approach to discovery uses artificial intelligence, deep learning, and genomics to rapidly and efficiently predict and then unlock the most health-benefiting components hidden within plants and natural food sources, called peptides. Nuritas has since established the world’s largest peptide knowledge base. Through its discoveries, Nuritas wants to firstly manage and improve human health and secondly help make our food system more sustainable by replacing current unwanted ingredients and molecules with more natural and sustainable ones.



Your cart